Pure Global

Clinical Trial - Trial ChiCTR-OPC-15006757

Access comprehensive clinical trial information for ChiCTR-OPC-15006757 through Pure Global AI's free database. This Phase 1 trial is sponsored by The First Affiliated Hospital of Nanjing Medical University and is currently Recruiting. The study focuses on Dry Age-related Macular Degeneration.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR-OPC-15006757
Phase 1
Recruiting
Trial Details
Chinese Clinical Trial Registry โ€ข ChiCTR-OPC-15006757
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Treatment of Dry Age-related Macular Degeneration using fetal retinal pigment epithelium

Study Focus

Sponsor & Location

The First Affiliated Hospital of Nanjing Medical University

National Program on Key Basic Research Project (973 Program)

China

Timeline & Enrollment

Phase 1

N/A

Jul 01, 2018

ICD-10 Classifications

Peripheral retinal degeneration
Corneal degeneration
Hereditary retinal dystrophy
Optic atrophy in diseases classified elsewhere
Disorders of choroid and retina

Data Source

Chinese Clinical Trial Registry

ChiCTR-OPC-15006757

Non-Device Trial